78 related articles for article (PubMed ID: 19821820)
1. [Inhibition of Autophagy Augments the Anticancer Activity of KPT-330 in Mantle Cell Lymphoma Cells].
Zhang YL; Chen YH; Zheng RJ; Zheng KJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):470-475. PubMed ID: 38660854
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticle siRNA cocktails for the treatment of mantle cell lymphoma.
Knapp CM; He J; Lister J; Whitehead KA
Bioeng Transl Med; 2018 May; 3(2):138-147. PubMed ID: 30065968
[TBL] [Abstract][Full Text] [Related]
3. HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosis.
Sokolova E; Guryev E; Yudintsev A; Vodeneev V; Deyev S; Balalaeva I
Oncotarget; 2017 Mar; 8(13):22048-22058. PubMed ID: 28423549
[TBL] [Abstract][Full Text] [Related]
4. Lipidoid nanoparticle mediated silencing of Mcl-1 induces apoptosis in mantle cell lymphoma.
Knapp CM; He J; Lister J; Whitehead KA
Exp Biol Med (Maywood); 2016 May; 241(9):1007-13. PubMed ID: 27022142
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of action of therapeutic antibodies for cancer.
Redman JM; Hill EM; AlDeghaither D; Weiner LM
Mol Immunol; 2015 Oct; 67(2 Pt A):28-45. PubMed ID: 25911943
[TBL] [Abstract][Full Text] [Related]
6. The development of immunoconjugates for targeted cancer therapy.
Smaglo BG; Aldeghaither D; Weiner LM
Nat Rev Clin Oncol; 2014 Nov; 11(11):637-48. PubMed ID: 25265912
[TBL] [Abstract][Full Text] [Related]
7. Linked-in: design and efficacy of antibody drug conjugates in oncology.
Feld J; Barta SK; Schinke C; Braunschweig I; Zhou Y; Verma AK
Oncotarget; 2013 Mar; 4(3):397-412. PubMed ID: 23651630
[TBL] [Abstract][Full Text] [Related]
8. Production of unique immunotoxin cancer therapeutics in algal chloroplasts.
Tran M; Van C; Barrera DJ; Pettersson PL; Peinado CD; Bui J; Mayfield SP
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):E15-22. PubMed ID: 23236148
[TBL] [Abstract][Full Text] [Related]
9. Antibody-based therapeutics for the treatment of human B cell malignancies.
Baskar S; Muthusamy N
Curr Allergy Asthma Rep; 2013 Feb; 13(1):33-43. PubMed ID: 23229130
[TBL] [Abstract][Full Text] [Related]
10. Combination treatments with ABT-263 and an immunotoxin produce synergistic killing of ABT-263-resistant small cell lung cancer cell lines.
Mattoo AR; FitzGerald DJ
Int J Cancer; 2013 Feb; 132(4):978-87. PubMed ID: 22821746
[TBL] [Abstract][Full Text] [Related]
11. Targeting malignant B cells with an immunotoxin against ROR1.
Baskar S; Wiestner A; Wilson WH; Pastan I; Rader C
MAbs; 2012; 4(3):349-61. PubMed ID: 22531447
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD22 antibody targeting of pH-responsive micelles enhances small interfering RNA delivery and gene silencing in lymphoma cells.
Palanca-Wessels MC; Convertine AJ; Cutler-Strom R; Booth GC; Lee F; Berguig GY; Stayton PS; Press OW
Mol Ther; 2011 Aug; 19(8):1529-37. PubMed ID: 21629223
[TBL] [Abstract][Full Text] [Related]
13. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer.
Weldon JE; Pastan I
FEBS J; 2011 Dec; 278(23):4683-700. PubMed ID: 21585657
[TBL] [Abstract][Full Text] [Related]
14. CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.
O'Reilly MK; Tian H; Paulson JC
J Immunol; 2011 Feb; 186(3):1554-63. PubMed ID: 21178016
[TBL] [Abstract][Full Text] [Related]
15. ABT-737 overcomes resistance to immunotoxin-mediated apoptosis and enhances the delivery of pseudomonas exotoxin-based proteins to the cell cytosol.
Traini R; Ben-Josef G; Pastrana DV; Moskatel E; Sharma AK; Antignani A; Fitzgerald DJ
Mol Cancer Ther; 2010 Jul; 9(7):2007-15. PubMed ID: 20587662
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxin BL22 induces apoptosis in mantle cell lymphoma (MCL) cells dependent on Bcl-2 expression.
Bogner C; Dechow T; Ringshausen I; Wagner M; Oelsner M; Lutzny G; Licht T; Peschel C; Pastan I; Kreitman RJ; Decker T
Br J Haematol; 2010 Jan; 148(1):99-109. PubMed ID: 19821820
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.
Biberacher V; Decker T; Oelsner M; Wagner M; Bogner C; Schmidt B; Kreitman RJ; Peschel C; Pastan I; Meyer Zum Büschenfelde C; Ringshausen I
Haematologica; 2012 May; 97(5):771-9. PubMed ID: 22180432
[TBL] [Abstract][Full Text] [Related]
18. ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents.
Touzeau C; Dousset C; Bodet L; Gomez-Bougie P; Bonnaud S; Moreau A; Moreau P; Pellat-Deceunynck C; Amiot M; Le Gouill S
Clin Cancer Res; 2011 Sep; 17(18):5973-81. PubMed ID: 21821698
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
